Russian company building blood products plant

Russia's Generium has started construction in the Vladimir region on what is being billed as Europe's largest biopharmaceutical plant. The facility is slated to make products that include antibodies, blood coagulants and albumin, Sputnik International reports. The work is slated to be complete in 2018. Report